Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

RXST - RxSight, Inc.

IEX Last Trade
34.28
0.210   0.613%

Share volume: 5,779
Last Updated: Fri 27 Dec 2024 08:30:10 PM CET

PREVIOUS CLOSE
CHG
CHG%
$34.07
0.21
0.62%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Historical prices Events Documents Notes Dividends
Performance
5 Days
1.33%
1 Month
-24.46%
3 Months
-27.79%
6 Months
-40.69%
1 Year
-14.30%
2 Year
209.90%
Key data
Stock price
$34.28
P/E Ratio 
0.00
DAY RANGE
$33.46 - $35.26
EPS 
$0.00
52 WEEK RANGE
$34.88 - $66.54
52 WEEK CHANGE
-$13.07
MARKET CAP 
2.098 B
YIELD 
N/A
SHARES OUTSTANDING 
37.196 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
1.93
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$825,270
AVERAGE 30 VOLUME 
$836,603
Company detail
CEO: Ronald M. Kurtz
Region: US
Website: rxsight.com
Employees: 220
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

RxSight, Inc. engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. The company was formerly known as Calhoun Vision, Inc.

Recent news